Endpoints News 2026-01-29 Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliff
Lonza News 2026-01-28 Lonza still intends to sell its capsules and health ingredients business - Endpoints News
Endpoints News 2026-01-28 FDA suspends Regenxbio gene therapy trials after patient developed brain tumor
Endpoints News 2026-01-28 HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch